Clinical Trial Update: Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. [Phase 2]

View source ↗

Summary

Clinical trial update on the efficacy of twice-daily LEO 124249 ointment 30 mg/g for eyebrow alopecia areata in a Phase 2 study that was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• LEO 124249 ointment 30 mg/g (LEO 124249)

Snippet

Sponsor: LEO Pharma | Conditions: Alopecia Areata | Phase 2 | Status: TERMINATED